NCT01351376

LLLT Combined With CDT in Breast Cancer-Related Lymphedema

The Effectiveness of Low Level Laser Therapy (LLLT)Combined With Complex Decongestive Therapy (CDT) in the Treatment of Breast Cancer-Related Lymphedema: A Double-Blind, Randomized, Placebo-Controlled Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 21 (actual)
• Sponsor: NYU Langone Health · Academic / Other
• Sex: Female
• Age: 21 Years
• Healthy volunteers: Not accepted

Summary

This study aims to explore the effects of Low Level Laser Therapy (LLLT) on breast cancer-related lymphedema when utilized in conjunction with Complex Decongestive Therapy (CDT) when compared to CDT treatment alone. The investigators hypothesize that the addition of LLLT to CDT will result in statistically significant improvements and greater long-term benefits as measured by changes in arm volume and quality of life when compared to the benefits of CDT alone for the treatment of breast cancer-related lymphedema.

Conditions

• Breast Cancer
• Lymphedema

Interventions

Type	Name	Description
DEVICE	Low Level Laser Therapy	Placebo LLL combined with CDT
DEVICE	Low Level Laser	Active LLL combined with CDT

Timeline

• Start date: 2011-05-01
• Primary completion: 2016-06-01
• Completion: 2017-07-01
• First posted: 2011-05-10
• Last updated: 2019-09-19
• Results posted: 2019-09-19

Locations

3 sites across 1 country: United States

Regulatory

• FDA-regulated device study